As expected, the vast majority of immune cell markers, such as CD163, S100A8, CD3, and FOXP3, showed higher expression levels in the TME compartment, while Ki-67, which was detected in proliferative tumor cells, was upregulated in tumor cells. The gene discussed is CD163; the disease is neoplasm.